HuGE Literature Finder
Records
1
-
4
Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Feb 19 (3): 699-709. Lévesque Éric, Huang Shu-Pin, Audet-Walsh Étienne, Lacombe Louis, Bao Bo-Ying, Fradet Yves, Laverdière Isabelle, Rouleau Mélanie, Huang Chao-Yuan, Yu Chia-Cheng, Caron Patrick, Guillemette Chant |
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jan 19 (1): 1. Setlur SR, Chen CX, Hossain RR, Ha JS, Van Doren VE, Stenzel B, Steiner E, Oldridge D, Kitabayashi N, Banerjee S, Chen JY, Schäfer G, Horninger W, Lee C, Rubin MA, Klocker H, Demichelis F |
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer. The Prostate 2008 Dec 68 (16): 1798-805. Scariano John K, Treat Eric, Alba Frances, Nelson Harold, Ness Scott A, Smith Anthony |
Inherited variation in hormone-regulating genes and prostate cancer survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Sep 13 (17): 5156-61. Lindström Sara, Adami Hans-Olov, Bälter Katarina Augustsson, Xu Jianfeng, Zheng S Lilly, Stattin Pär, Grönberg Henrik, Wiklund Fredr |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: